IMS Japan provides top-line
pharmaceutical-industry information and insights pertaining to market scale,
drug effectiveness, sales by manufacturer and by drug, medical conditions, and
prescribing information, for limited use by the media and academic institutions
involved in medical treatment and research. Our objective is to enhance the
public’s awareness of the healthcare industry and of the various trends relating
to disease treatments, while furthering society’s understanding of the Japanese
pharmaceutical market. By making such top-line data available, IMS hopes to
contribute to the improvement of healthcare in Japan through the broad-based
sharing and understanding of this market information.
